Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.98 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.98 |
| ▸ | MMP3 | P08254 | 7/20 | 0.62 |
| ▸ | MMP8 | P22894 | 7/20 | 0.62 |
| ▸ | MMP9 | P14780 | 6/20 | 0.62 |
| ▸ | KARS1 | Q15046 | 3/20 | 0.61 |
| ▸ | RXRA | P19793 | 1/20 | 0.61 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.61 |
| ▸ | CDK2 | P24941 | 1/20 | 0.61 |
| ▸ | RXRB | P28702 | 1/20 | 0.61 |
| ▸ | RXRG | P48443 | 1/20 | 0.61 |
| ▸ | POLA1 | P09884 | 4/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | APEX1 | P27695 | 1/20 | 0.55 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ecabet SCHEMBL10935978 | 1.00 | NR1I2 (0.98) | NR1I2OPRK1MMP3MMP8MMP9 | |
| Ecabet SCHEMBL7615516 | 1.00 | NR1I2 (0.98) | NR1I2OPRK1MMP3MMP8MMP9 | |
| Ecabet SCHEMBL10938694 | 1.00 | NR1I2 (0.98) | NR1I2OPRK1MMP3MMP8MMP9 | |
| Ecabet SCHEMBL17747954 | 0.99 | NR1I2 (0.96) | NR1I2OPRK1MMP3MMP8MMP9 | |
| Ecabet SCHEMBL6546246 | 0.99 | NR1I2 (1.00) | NR1I2OPRK1MMP3MMP8MMP9 | |
| Ecabet SCHEMBL29727401 | 0.99 | NR1I2 (1.00) | NR1I2OPRK1MMP3MMP8MMP9 | |
| Ecabet SCHEMBL373030 | 0.99 | NR1I2 (1.00) | NR1I2OPRK1MMP3MMP8MMP9 | |
| Ecabet SCHEMBL8614405 | 0.99 | NR1I2 (1.00) | NR1I2OPRK1MMP3MMP8MMP9 | |
| Ecabet SCHEMBL10937325 | 0.98 | NR1I2 (0.98) | NR1I2OPRK1MMP3MMP8MMP9 | |
| Ecabet SCHEMBL10938701 | 0.98 | NR1I2 (0.98) | NR1I2OPRK1MMP3MMP8MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116903498-A | Synthesis method of ecabet sodium | 江苏亚邦强生药业有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-219707363-U | Sub-packaging equipment for ecabet sodium particles | 江苏亚邦强生药业有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-216726940-U | Full-automatic oscillation instrument for preparing ecabet particles | 江苏亚邦强生药业有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-216709697-U | Ultra-precision metering equipment for packaging ecabet sodium particles | 江苏亚邦强生药业有限公司 | 2022-06-10 | — | — | CN | claimed |
| EP-3773907-A1 | METHODS OF DISRUPTING A BIOFILM AND/OR PREVENTING FORMATION OF SAME | Yeda Research and Development Co. Ltd (IL) | 2021-02-17 | — | — | EP | claimed |
| US-20210015889-A1 | METHODS OF DISRUPTING A BIOFILM AND/OR PREVENTING FORMATION OF SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-01-21 | — | — | US | claimed |
| US-20200325543-A1 | DIAGNOSTIC METHOD | TOLREMO THERAPEUTICS AG (CH) | 2020-10-15 | — | — | US | claimed |
| EP-3714069-A1 | DIAGNOSTIC METHOD | Tolremo Therapeutics AG (CH) | 2020-09-30 | — | — | EP | claimed |
| CN-111417730-A | Diagnostic method | 托雷莫治疗股份公司 | 2020-07-14 | — | — | CN | claimed |
| CN-111377836-A | Crystal form of ecabet sodium and preparation method thereof | 四川科瑞德制药股份有限公司 | 2020-07-07 | — | — | CN | claimed |
| CN-1703150-A | Low moisture chewing gum | GUMLINK AS (DK) | 2005-11-30 | — | — | CN | claimed |
| WO-2005110473-A2 | METHODS AND ARTICLES FOR THE DELIVERY OF MEDICAMENTS TO THE EYE FOR THE TREATMENT OF POSTERIOR SEGMENT DISEASES | DIRECTCONTACT LLC (US) | 2005-11-24 | — | — | WO | claimed |
| US-20050255144-A1 | Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases | DIRECTCONTACT LLC | 2005-11-17 | — | — | US | claimed |
| CN-1668206-A | Chewing gum having improved release of chewing gum ingredients | GUMLINK AS (DK) | 2005-09-14 | — | — | CN | claimed |
| CN-1668207-A | Degradable chewing gum polymer | GUMLINK AS (DK) | 2005-09-14 | — | — | CN | claimed |
| CN-1668208-A | Chewing gum comprising at least two different biodegradable polymers | GUMLINK AS (DK) | 2005-09-14 | — | — | CN | claimed |
| CN-1668209-A | Biodegradable chewing gum comprising at least one high molecular weight biodegradable polymer | GUMLINK AS (DK) | 2005-09-14 | — | — | CN | claimed |
| CN-1596108-A | Aqueous ECABET sodium solution preparation | TANABE SEIYAKU CO (JP) | 2005-03-16 | — | — | CN | claimed |
| US-20040259905-A1 | Aqueous ecabet sodium solution preparation | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2004-12-23 | — | — | US | claimed |
| EP-1430892-A1 | AQUEOUS ECABET SODIUM SOLUTION PREPARATION | TANABE SEIYAKU CO., LTD. (JP) | 2004-06-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259905-A1 | Aqueous ecabet sodium solution preparation | SLC10A2, SI, SLC5A6 | NR1I2 3670/4885OPRK1 3169/4885MMP3 3370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.